Type | Public | |
Founded | 1994 | |
Website | panaceabiotec.com | |
Employee Ratings |
INR | |
---|---|
Revenue (Q3, 2022) | 1.6b |
Gross profit (Q3, 2022) | 1.1b |
Net income (Q3, 2022) | (492.0m) |
EBITDA (Q3, 2022) | 135.2m |
EBIT (Q3, 2022) | 29.7m |
Market capitalization (17-Jun-2022) | 7.8b |
Closing stock price (17-Jun-2022) | 127.8 |
EV | 7.8b |
INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Revenue | 5.7b | 4.5b | 5.4b | 6.2b |
Cost of goods sold | (2.1b) | (2.0b) | (1.7b) | (2.3b) |
Gross profit | 3.9b | 2.6b | 3.7b | 4.0b |
R&D expense | (618.1m) | (247.7m) |
INR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 951.1m | 1.2b | 1.1b | 1.3b | 1.3b | 1.7b | 1.3b | 1.8b | 1.4b | 1.3b | 2.3b | 1.6b |
Cost of goods sold | (314.1m) | (408.5m) | (317.6m) | (280.7m) | (368.9m) | (522.8m) | (394.4m) | (638.0m) | (425.1m) | (426.3m) | (1.0b) | (465.9m) |
Gross profit | 670.3m | 810.3m | 862.1m | 1.0b | 917.4m | 1.2b | 945.1m | 1.2b | 1.0b | 930.5m | 1.3b | 1.1b |
INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Cash | 232.4m | 234.8m | 897.5m | 1.4b |
Accounts Receivable | 1.4b | 887.3m | 685.2m | 846.8m |
Prepaid Expenses | 110.5m | 116.0m | 141.5m | 118.1m |
Inventories | 3.3b | 814.3m | 1.5b | 1.7b |
INR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 162.2m | 1.2b | 1.0b | 1.4b | ||||||||
Accounts Receivable | 1.2b | 858.3m | 942.1m | 1.2b | ||||||||
Inventories | 1.4b | 1.1b | 1.5b | 2.1b |
INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Net Income | (661.4m) | 462.3m | (1.7b) | (1.4b) |
Depreciation and Amortization | 585.3m | 550.3m | 441.4m | 460.7m |
Inventories | (188.3m) | 847.6m | (662.6m) | (264.4m) |
Accounts Payable | 312.7m | 75.1m | (496.9m) | 235.1m |
INR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (983.3m) | (523.6m) | (1.1b) | |||||||||
Depreciation and Amortization | 229.0m | 231.9m | 219.7m | |||||||||
Inventories | (270.9m) | (49.5m) | (332.0m) | |||||||||
Accounts Payable | (688.7m) | 182.9m | 1.3b |
Panacea Biotec revenue breakdown by business segment: 63.5% from FORMULATIONS and 36.5% from VACCINES
Panacea Biotec has 877 Twitter Followers. The number of followers has decreased 0.1% month over month and increased 1% quarter over quarter
When was Panacea Biotec founded?
Panacea Biotec was founded in 1994.
How many employees does Panacea Biotec have?
Panacea Biotec has 2,600 employees.
What is Panacea Biotec revenue?
Latest Panacea Biotec annual revenue is ₹6.2 b.
What is Panacea Biotec revenue per employee?
Latest Panacea Biotec revenue per employee is ₹2.4 m.
Who are Panacea Biotec competitors?
Competitors of Panacea Biotec include Centrient Pharmaceuticals, Procos and Medley Pharmaceuticals.
Receive alerts for 300+ data fields across thousands of companies